Large gap with delayed quotes
|
Last quote
06/18/2026
-
02:00:00
|
Bid
06/18/2026 -
10:09:34
|
Bid Volume |
Ask
06/18/2026 -
10:09:34
|
Ask Volume |
|---|---|---|---|---|
|
551.47
+3.20
(
+0.58% )
|
392.36
|
40 |
640.92
|
40 |
Analysis date: 16.06.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 09.06.2026.
Interest
Very weak
Very weak
One star since 02.06.2026.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 26.05.2026 at a price of 578.43.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 02.06.2026.
4wk Rel Perf
-4.96%
-4.96%
The four-week dividend-adjusted underperformance versus SP500 is 4.96%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 09.06.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.61%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.56%.
Mkt Cap in $bn
23.33
23.33
With a market capitalization >$8bn, UNITED THERAPEUTICS is considered a large-cap stock.
G/PE Ratio
1.14
1.14
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
11.43
11.43
The estimated PE is for the year 2029.
LT Growth
13.06%
13.06%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
8
8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
34
34
For 1% of index variation, the stock varies on average by 0.34%.
Correlation
0.07
0.07
Stock movements are totally independent of index variations.
Value at Risk
63
63
The value at risk is estimated at USD 63.00. The risk is therefore 11.49%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
08.06.2005
08.06.2005